Literature DB >> 18250610

Two common and three novel PDS mutations in Thai patients with Pendred syndrome.

T Snabboon1, W Plengpanich, S Saengpanich, S Sirisalipoch, S Keelawat, S Sunthornyothin, W Khovidhunkit, S Suwanwalaikorn, V Sridama, V Shotelersuk.   

Abstract

Pendred syndrome is an autosomal recessive disorder characterized by congenital sensorineural deafness, goiter, and impaired iodide organification. It is caused by mutations in the PDS gene. Most published mutation studies of Pendred syndrome have dealt with Western populations. In this study, we examined clinical and molecular characteristics of 16 affected individuals in 6 unrelated Thai families. Of all the affected, 100% (16/16) had bilateral deafness, 68.8% (11/16) goiters, and 25% (4/16) hypothyroidism. Follicular thyroid carcinoma and Hürthle cell adenoma were found in affected members of a family, raising the possibility of an increased risk of thyroid carcinoma in Pendred syndrome patients. Sequence analysis of the entire coding region of the PDS gene successfully identified all 12 mutant alleles in these 6 families. The 12 identified mutant alleles constituted 6 distinct mutations including 3 splice site mutations (IVS4-1G>A, IVS7-2A>G, IVS9- 1G>A), one frame shift mutation (1548insC) and 2 missense mutations (T67S, H723R). Eight mutations out of 12 were constituted by IVS7- 2A>G and 1548insC, each one being present in 4 distinct alleles in our studied group. The identification of these two frequent PDS mutations will facilitate the molecular diagnosis of Pendred syndrome in Thai populations. In addition, three newly identified mutations, T67S, IVS4-1G>A, and IVS9-1G>A, were not observed in 50 unrelated healthy Thai controls.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18250610     DOI: 10.1007/BF03349236

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion.

Authors:  I E Royaux; S M Wall; L P Karniski; L A Everett; K Suzuki; M A Knepper; E D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes.

Authors:  Nicole Pfarr; Guntram Borck; Andrew Turk; Ulrike Napiontek; Annerose Keilmann; Wibke Müller-Forell; Peter Kopp; Joachim Pohlenz
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

3.  Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness.

Authors:  H-J Park; S Shaukat; X-Z Liu; S H Hahn; S Naz; M Ghosh; H-N Kim; S-K Moon; S Abe; K Tukamoto; S Riazuddin; M Kabra; R Erdenetungalag; J Radnaabazar; S Khan; A Pandya; S-I Usami; W E Nance; E R Wilcox; S Riazuddin; A J Griffith
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

4.  The diagnosis of malignancy in dyshormonogenetic goitre.

Authors:  A L Vickery
Journal:  Clin Endocrinol Metab       Date:  1981-07

5.  Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations.

Authors:  S Usami; S Abe; M D Weston; H Shinkawa; G Van Camp; W J Kimberling
Journal:  Hum Genet       Date:  1999-02       Impact factor: 4.132

6.  Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues.

Authors:  J M Bidart; C Mian; V Lazar; D Russo; S Filetti; B Caillou; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Mutations of the Pendred syndrome gene (PDS) in patients with large vestibular aqueduct.

Authors:  K Kitamura; K Takahashi; Y Noguchi; Y Kuroishikawa; Y Tamagawa; K Ishikawa; K Ichimura; H Hagiwara
Journal:  Acta Otolaryngol       Date:  2000-03       Impact factor: 1.494

8.  Long-term follow-up of hearing loss in children and young adults with enlarged vestibular aqueducts: relationship to radiologic findings and Pendred syndrome diagnosis.

Authors:  Ian B Colvin; Timothy Beale; Katherine Harrop-Griffiths
Journal:  Laryngoscope       Date:  2006-11       Impact factor: 3.325

9.  Two frequent missense mutations in Pendred syndrome.

Authors:  P Van Hauwe; L A Everett; P Coucke; D A Scott; M L Kraft; C Ris-Stalpers; C Bolder; B Otten; J J de Vijlder; N L Dietrich; A Ramesh; S C Srisailapathy; A Parving; C W Cremers; P J Willems; R J Smith; E D Green; G Van Camp
Journal:  Hum Mol Genet       Date:  1998-07       Impact factor: 6.150

10.  Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene.

Authors:  G Medeiros-Neto; M J Gil-Da-Costa; C L Santos; A M Medina; J C Silva; R M Tsou; M Sobrinho-Simões
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

View more
  5 in total

Review 1.  Familial follicular cell tumors: classification and morphological characteristics.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

2.  Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting.

Authors:  Neng Chen; Lisbeth Tranebjærg; Nanna Dahl Rendtorff; Iris Schrijver
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

3.  Developmental delays consistent with cochlear hypothyroidism contribute to failure to develop hearing in mice lacking Slc26a4/pendrin expression.

Authors:  Philine Wangemann; Hyoung-Mi Kim; Sara Billings; Kazuhiro Nakaya; Xiangming Li; Ruchira Singh; David S Sharlin; Douglas Forrest; Daniel C Marcus; Peying Fong
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-19

Review 4.  Genetic susceptibility to hereditary non-medullary thyroid cancer.

Authors:  Tina Kamani; Parsa Charkhchi; Afshan Zahedi; Mohammad R Akbari
Journal:  Hered Cancer Clin Pract       Date:  2022-03-07       Impact factor: 2.857

Review 5.  Personalized medicine: caught between hope, hype and the real world.

Authors:  Marc Dammann; Frank Weber
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.